The FERM-Domain Protein Expanded Regulates Hippo Pathway Activity via Direct Interactions with the Transcriptional Activator Yorkie

被引:188
作者
Badouel, Caroline [1 ,2 ]
Gardano, Laura [1 ,2 ,3 ]
Amin, Nancy [1 ,2 ]
Garg, Ankush [1 ,2 ]
Rosenfeld, Robyn [1 ,2 ]
Le Bihan, Thierry [4 ]
McNeill, Helen [1 ,2 ]
机构
[1] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X5, Canada
[3] Welcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland
[4] Univ Edinburgh, CSBE, Edinburgh EH9 3JR, Midlothian, Scotland
基金
英国生物技术与生命科学研究理事会;
关键词
ORGAN SIZE CONTROL; CELL-CYCLE EXIT; TUMOR-SUPPRESSOR PATHWAY; SIGNALING PATHWAY; PROMOTES APOPTOSIS; CONTACT INHIBITION; TEAD/TEF FAMILY; DROSOPHILA; PROLIFERATION; GROWTH;
D O I
10.1016/j.devcel.2009.01.010
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The Hippo kinase pathway plays a central role in growth regulation and tumor suppression from flies to man. The Hippo/Mst kinase phosphorylates and activates the NDR family kinase Warts/Lats, which phosphorylates and inhibits the transcriptional activator Yorkie/YAP. Current models place the FERM-domain protein Expanded upstream of Hippo kinase in growth control. To understand how Expanded regulates Hippo pathway activity, we used affinity chromatography and mass spectrometry to identify Expanded-binding proteins. Surprisingly we find that Yorkie is the major Expanded-binding protein in Drosophila S2 cells. Expanded binds Yorkie at endogenous levels via WW-domain-PPxY interactions, independently of Yorkie phosphorylation at S168, which is critical for 14-3-3 binding. Expanded relocalizes Yorkie from the nucleus, abrogating its nuclear activity, and it can regulate growth downstream of warts in vivo. These data lead to a new model whereby Expanded functions downstream of Warts, in concert with 14-3-3 proteins to sequester Yorkie in the cytoplasm, inhibiting growth activity of the Hippo pathway.
引用
收藏
页码:411 / 420
页数:10
相关论文
共 42 条
  • [1] Yorkie and Scalloped: Partners in growth activation
    Bandura, Jennifer L.
    Edgar, Bruce A.
    [J]. DEVELOPMENTAL CELL, 2008, 14 (03) : 315 - 316
  • [2] Fat cadherin modulates organ size in Drosophila via the Salvador/Warts/Hippo signaling pathway
    Bennett, F. Christian
    Harvey, Kieran F.
    [J]. CURRENT BIOLOGY, 2006, 16 (21) : 2101 - 2110
  • [3] The Drosophila tumor suppressor expanded regulates growth, apoptosis, and patterning during development
    Blaumueller, CM
    Mlodzik, M
    [J]. MECHANISMS OF DEVELOPMENT, 2000, 92 (02) : 251 - 262
  • [4] BOEDIGHEIMER M, 1993, DEVELOPMENT, V118, P1291
  • [5] Boedigheimer MJ, 1997, DEV GENET, V20, P103, DOI 10.1002/(SICI)1520-6408(1997)20:2<103::AID-DVG3>3.3.CO
  • [6] 2-M
  • [7] Delineation of a Fat tumor suppressor pathway
    Cho, Eunjoo
    Feng, Yongqiang
    Rauskolb, Cordelia
    Maitra, Sushmita
    Fehon, Rick
    Irvine, Kenneth D.
    [J]. NATURE GENETICS, 2006, 38 (10) : 1142 - 1150
  • [8] Elucidation of a universal size-control mechanism in Drosophila and mammals
    Dong, Jixin
    Feldmann, Georg
    Huang, Jianbin
    Wu, Shian
    Zhang, Nailing
    Comerford, Sarah A.
    Gayyed, Mariana F.
    Anders, Robert A.
    Maitra, Anirban
    Pan, Duojia
    [J]. CELL, 2007, 130 (06) : 1120 - 1133
  • [9] From cell structure to transcription: Hippo forges a new path
    Edgar, BA
    [J]. CELL, 2006, 124 (02) : 267 - 273
  • [10] SCALLOPED interacts with YORKIE, the nuclear effector of the hippo tumor-suppressor pathway in Drosophila
    Goulev, Youlian
    Fauny, Jean Daniel
    Gonzalez-Marti, Beatriz
    Flagiello, Domenico
    Silber, Joeel
    Zider, Alain
    [J]. CURRENT BIOLOGY, 2008, 18 (06) : 435 - 441